3 Questions: Sara Seager on the discovery of a ‘new’ form of life
The MIT planetary scientist discusses what the finding means for life on Earth and elsewhere in the universe.
When gender isn’t written all over one’s face
Neuroscientists find that the same face may look male or female, depending on where it appears in a person’s field of view.
Timing is everything for cancer protein p53
Biologists find that restoring the gene for p53 can slow the spread of advanced lung tumors, but doesn’t help early-stage cancers.
Lindquist receives National Medal of Science
President Obama presents nation’s top science awards at White House ceremony Wednesday.
Turning off cancer genes
RNA interference holds much promise as a cancer treatment, but technical challenges remain.
A better way to target tumors
In spite of slow progress toward targeting cancer drugs to individual patients, hope remains.
Tuning in to a new hearing mechanism
Findings from MIT scientists could lead to hearing aids that mimic the ear’s ability to focus on particular frequencies.
A new target for cancer drugs
Shutting down an enzyme that responds to DNA damage could boost the effects of traditional chemotherapy.
7 win presidential early career honors
MIT has greatest number of recipients from a single institution.
Cancer’s hiding spots revealed
Discovery that tumor cells can escape from chemotherapy could lead to new treatments that prevent relapse.
Force of habit
New study shows that costs and rewards of behavior help the brain form optimal habits.
Going nature one better
MIT researchers aim to learn biology’s secrets for making tough, resilient materials out of simple components, and then improve on them.
Fueling up for 26.2 miles
HST student develops model that can help marathon runners pace themselves to a strong finish.
Younger brains are easier to rewire
Study of blind patients supports the idea that there is a period early in a person’s development when brain regions can switch functions.
Teasing out malaria’s genetic secrets
Biological engineer’s new approach to studying gene control could lead to new drug targets.